Marcos Duarte de Mattos

ORCID: 0000-0002-5069-8051
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Brain Metastases and Treatment
  • Breast Implant and Reconstruction
  • Breast Cancer Treatment Studies
  • Glioma Diagnosis and Treatment
  • Salivary Gland Tumors Diagnosis and Treatment
  • Maternal and Neonatal Healthcare
  • Head and Neck Cancer Studies
  • Women's cancer prevention and management
  • Radiopharmaceutical Chemistry and Applications
  • Esophageal and GI Pathology
  • Management of metastatic bone disease
  • Occupational and environmental lung diseases
  • Head and Neck Surgical Oncology
  • Histone Deacetylase Inhibitors Research
  • Pharmaceutical Economics and Policy
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Global Cancer Incidence and Screening
  • Facial Rejuvenation and Surgery Techniques
  • Public Health in Brazil
  • Hedgehog Signaling Pathway Studies
  • Chemical Reactions and Isotopes
  • Effects of Radiation Exposure
  • Gastric Cancer Management and Outcomes
  • Health Systems, Economic Evaluations, Quality of Life
  • Esophageal Cancer Research and Treatment

Hospital de Câncer de Barretos
2009-2023

Hospital São Paulo
2023

Universidade Federal de São Paulo
2002

Observou-se que há pouco debate acerca da violência contra pessoas LGBTQIAP+. Assim, o estudo se apresenta necessário para melhor compreensão, propondo a investigar e ampliar, as discussões, criminalidade no estado do Pará durante período de pandemia Covid-19 com enfoque à população Será abordado uma análise cenários das denúncias recebidas pelos órgãos segurança pública permitido identificar prevalência, motivações, formas fatores em relação violências ocorridas distribuição espacial...

10.56238/arev7n4-296 article PT Aracê. 2025-04-29

The purpose of this phase II trial was to evaluate the tolerability, safety, and efficacy a non-5-fluorouracil (5-FU)-based induction chemotherapy followed by chemoradiotherapy (CRT) for patients with locally advanced head neck squamous cell carcinoma (HNSCC).Sixty stage III IV HNSCC were treated paclitaxel cisplatin (TP; 175 mg/m(2) 80 , 3 cycles) CRT (cisplatin 100 ; D1, 22, 43 radiotherapy).Fifty-six (93.3%) completed cycles TP (no treatment-related deaths), 52 (86.7%) definitive per...

10.1002/hed.24137 article EN Head & Neck 2015-05-28

OBJETIVO: Investigar no pulmão, por imunohistoquímica, a localização das proteínas TGFbeta1 latente e ativa, se ocorre ativação radioinduzida da proteína distribuição fibras colágenas em diversos períodos de tempo após irradiação. MÉTODOS: 32 camundongos isogênicos (C57BL) foram divididos dois grupos: GI (não irradiado) com 12 animais GII (irradiado) 20 animais. Os do receberam radiação gama (telecobaltoterapia, 60Co, rendimento 0,97Gy/min, dose única 7Gy corpo inteiro). dos grupos I II...

10.1590/s0104-42302002000400039 article PT cc-by Revista da Associação Médica Brasileira 2002-12-01

Radiosurgery for multiple brain metastases has been more reported recently without using whole-brain radiotherapy. Nevertheless, the sparsity of data still claims information about toxicity and survival their association with both dosimetric geometric aspects this treatment.To assess outcome radiosurgery in patients (four or lesions) metastases.In a single institution, were collected retrospectively from who underwent to treat diverse primary sites. Patients 4-21 treated fraction dose 18 Gy...

10.5306/wjco.v14.i10.400 article EN World Journal of Clinical Oncology 2023-10-20

e17507 Background: Tumor volume and the ratio of volumetric change have been demonstrated to a prognostic role in head neck cancers during definitive treatment LAHNSCC. The aim this study was evaluate value tumor assessment IC. Methods: We retrospectively assessed 58 pts with LAHNSCC included prospective phase II trial which evaluated safety non–5-fluorouracil-based IC (paclitaxel; cisplatin) followed by chemoradiotherapy (cisplatin; 70Gy/35fx) 2009-2012. primary (P rim V), all suspicious...

10.1200/jco.2017.35.15_suppl.e17507 article EN Journal of Clinical Oncology 2017-05-20
Coming Soon ...